Simultaneous quantification of the 22-kDa isoforms of human growth hormone 1 and 2 in human plasma by multiplexed immunocapture and LC-MS/MS

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
128 Downloads (Pure)

Abstract

An LC-MS/MS method is presented for the simultaneous quantification of two structurally closely related protein biomarker isoforms, the 22-kDa isoforms of human growth hormone 1 and human growth hormone 2, in human plasma. It is based on multiplexed immunocapture using two monoclonal antibodies immobilized on magnetic beads, tryptic digestion and quantification of two specific signature peptides plus an additional peptide for estimation of total growth hormone related concentrations. A full validation according to international guidelines was performed across the clinically relevant concentration ranges of 0.5 to 50 ng/mL for growth hormone 1, and 2 to 50 ng/mL for growth hormone 2 and demonstrated satisfactory method performance in terms of accuracy, precision, stability and absence of interference. The method's applicability for routine analysis and its ability to effectively distinguish between GH1 and GH2 was demonstrated by the analysis of plasma samples from pregnant individuals to study the changes in growth hormone levels during pregnancy.

Original languageEnglish
Article number117736
Number of pages9
JournalClinica chimica acta
Volume554
DOIs
Publication statusPublished - 1-Feb-2024

Keywords

  • Biomarker
  • Human growth hormone 1
  • Human growth hormone 2
  • Immunocapture
  • Isoform
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS)

Fingerprint

Dive into the research topics of 'Simultaneous quantification of the 22-kDa isoforms of human growth hormone 1 and 2 in human plasma by multiplexed immunocapture and LC-MS/MS'. Together they form a unique fingerprint.

Cite this